Department of Allergy and Immunology, Birmingham Heartlands Hospital, UK.
Clin Exp Immunol. 2011 Feb;163(2):131-46. doi: 10.1111/j.1365-2249.2010.04296.x. Epub 2010 Dec 22.
Allergen immunotherapy describes the treatment of allergic disease through administration of gradually increasing doses of allergen. This form of immune tolerance induction is now safer, more reliably efficacious and better understood than when it was first formally described in 1911. In this paper the authors aim to summarize the current state of the art in immunotherapy in the treatment of inhalant, venom and drug allergies, with specific reference to its practice in the United Kingdom. A practical approach has been taken, with reference to current evidence and guidelines, including illustrative protocols and vaccine schedules. A number of novel approaches and techniques are likely to change considerably the way in which we select and treat allergy patients in the coming decade, and these advances are previewed.
变应原免疫疗法通过逐渐增加变应原剂量来描述过敏性疾病的治疗。与 1911 年首次正式描述时相比,这种免疫耐受诱导形式现在更安全、更可靠、更有效,也更容易理解。本文作者旨在总结目前在吸入物、毒液和药物过敏治疗中的免疫疗法的最新进展,特别提到其在英国的实践。采用了一种实用的方法,参考了当前的证据和指南,包括说明性方案和疫苗接种计划。在未来十年中,许多新的方法和技术可能会极大地改变我们选择和治疗过敏患者的方式,本文对此进行了展望。